Regent Pacific Group Limited (HKG:0575)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.600
-0.020 (-3.23%)
Apr 29, 2026, 4:08 PM HKT
-11.76%
Market Cap 175.09M
Revenue (ttm) 2.83M
Net Income (ttm) -36.66M
Shares Out 291.82M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,000
Average Volume 47,637
Open 0.600
Previous Close 0.620
Day's Range 0.600 - 0.600
52-Week Range 0.580 - 1.240
Beta 1.35
RSI 13.32
Earnings Date Mar 26, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholog... [Read more]

Sector Healthcare
Founded 1991
Employees 16
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0575
Full Company Profile

Financial Performance

In 2025, Regent Pacific Group's revenue was $363,000, a decrease of -49.51% compared to the previous year's $719,000. Losses were -$4.71 million, 5.09% more than in 2024.

Financial numbers in USD Financial Statements

News

There is no news available yet.